Simcere (å 声å¶čÆ) IPO: Fairly Valued for a Generic Player
We think the company is fairly valued but will participate in the deal given the likely strong sentiment as the deal is backed by decent...
466 Views
ECM Weekly (11 October 2020) - Excellence Comm, MR DIY, Converge ICT, Simcere, SciClone, JW Thera
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...
599 Views
A Different Angle -Ā Simcere Pharmaceutical VS Everest Medicines (01952.HK)
Everest Medicines was listed in Hong Kong stock market on October 9, 2020 and closed at HK$72.75 (up 32.27% on the first day) . From the...
587 Views
Simcere Pharmaceutical IPO Initiation: A Rough Patch?
The timing of the IPO is not ideal as Simcere is coming off a weak 1H20. However, Simcere is putting in place the right measures to ensure that the...
511 Views
Simcere (å 声å¶čÆ) Pre-IPO: PHIP Updates and Peer Comparison
Simcere Pharma has a long history dating back to 1995 and was previously listed in the US. The company is looking to raise USD 500m via a listing...
590 Views